Stanford Study: Breakthrough Treatment Protects Kids From Deadly Food Allergies

A Stanford Medicine-led study discovered that a medication capable of attaching to antibodies responsible for allergies can safeguard children against severe reactions from unintentional consumption of allergy-triggering foods.

A new study led by scientists at Stanford School of Medicine has found that a drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods.

The research was recently published in the New England Journal of Medicine. The findings suggest that regular use of the drug, omalizumab, could protect people from severe allergic responses, such as difficulty breathing, if they accidentally eat a small amount of a food they are allergic to.